References
- McGuigan J E. Peptic ulcer and gastritis. Harrison's principles of internal medicine, J D Wilson, E Braunwald, K J Isselbacher. McGraw Hill, New York 1991; 1229–48
- Recavarren-Arce S, Leon-Barua R, Cok J. Helicobacter pylori and progressive gastric pathology that predisposes to gastric cancer. Scand J Gastroenterol 1991; S181: 51–7
- Mardh S, Song Y H. Characterization of antigenic structure in autoimmune atrophic gastritis with pernicious anaemia: the parietal cell H+,K-ATPase and the chief cell pepsinogen are the two major antigens. Acta Physiol Scand 1989; 136: 581–7
- Burman P, Mardh S, Norberg L. Parietal cell antibodies in pernicious anemia inhibit H+, K+ -adenosine triphosphatase, the proton pump of the stomach. Gastroenterology 1989; 91: 1434–8
- Tanaka N, Glass G. Effects of prolonged administration of parietal cell antibodies from patients with atrophic gastritis and pernicious anemia on the parietal cell mass and hydrochlorhydric acid output in rats. Gastroenterology 1970; 58: 482–94
- Karlsson A, Burman P, Loof P. Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H,K-adenosine triphosphatase of the stomach. J Clin Invest 1988; 81: 475–9
- Burstein M, Monge E, Leon-Barua R. Low peptic ulcer and high gastric cancer prevalence in a developing country with a high prevalence of infection by Helicobacter pylori. J Clin Gastroenterol 1991; 13: 154–6
- Klein P D, The Gastrointestinal Physiology Working Group of Cayetano Heredia and Johns Hopkins University, Graham D Y. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Lancet 1991; 337: 1503–6
- Dooley C P, Cohen H, Fitzgibbons P L. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562–6
- Gilman R H, Leon-Barua R, Cok J. Rapid identification of pyloric Campylobacter in Peruvians with gastritis. Dig Dis Sci 1986; 31: 1089–94
- Glass G BJ. Immunology of atrophic gastritis. NY State J Med 1977; 9: 1697–705
- Bernhardt H, Burkett L L, Fields M L. The diagnostic significance of the parietal cell immunofluorescence test. Ann Intern Med 1965; 4: 635–41
- Correa P, Haenszel W, Cuello C. A model for gastric cancer epidemiology. Lancet 1975; 2: 58–62
- Ungar B, Strickland R G, Francis C M. The prevalence and significance of circulating antibodies to gastric intrinsic factor and parietal cells in gastric carcinoma. Gut 1971; 12: 903–5
- Siurala M, Lehtola J, Ihamaki T. Atrophic gastritis and its sequelae. Results of 19–23 years follow-up examinations. Scand J Gastroenterol 1974; 9: 441–6
- Kokkonen J. Parietal cell antibodies and gastric secretion in children with diabetes mellitus. Acta Paediatr Scand 1990; 69: 485–9
- Elson C O. Do organ-specific suppressor T cells prevent autoimmune gastritis?. Gastroenterology 1990; 98: 224–9
- Meehan R T. Immune suppression at high altitude. Ann Emerg Med 1987; 16: 974–9
- Krupina T N, Korotaev M M, Pukhova Y I. Comparative evaluation of studies of different levels of hypoxia on the human immunobiological status. Kosm Biol Aviakosm 1975; 11: 38–43
- Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano Heredia and The Johns Hopkins University, Ramirez-Ramos A, Gilman R. Ecology of Helicobacter pyloriin Peru: infection rates in coastal, high altitude, andjungle communities. Gut 1992; 33: 604–5
- Jaskiewicz K, Louwrens H D, Woodroof C W. The association of Campylobacter pylori with mucosal pathological changes in a population at risk for gastric cancer. S Afr Med J 1989; 75: 417–9
- Negrini R, Lisato L, Zanella I. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991; 101: 437–45